SEC Tracker
Get the app

MEI Pharma LITS

MEI Pharma: securities offering (amended)

Form
S-3/A
Filed
Importance
Routine
Document
S-3/A

Not explained yet; the original is on EDGAR.

Securities offering (amended)

View on EDGAR

Open in the app

Get an email when MEI Pharma files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Actinium Pharmaceuticals ATNM public float $44M, Jun 30, 2025
  2. Fortress Biotech FBIO public float $44M, Jun 30, 2025
  3. Actuate Therapeutics ACTU public float $42M, Jun 30, 2025
  4. Acumen Pharmaceuticals ABOS public float $45M, Jun 30, 2025
  5. Opus Genetics IRD public float $46M, Jun 30, 2025